Brazil
DavidLegge (Talk | contribs) |
DavidLegge (Talk | contribs) |
||
| Line 1: | Line 1: | ||
| + | Blah | ||
| + | |||
'''Brazil breaks AIDS drug patent with generic version from India''' <br /> | '''Brazil breaks AIDS drug patent with generic version from India''' <br /> | ||
May 5, 2007: Brazil President Luiz Inacio Lula da Silva has authorised the country to break the patent on an AIDS drug made by Merck & Co - importing a generic version from India instead. It`s the first time Brazil has bypassed a patent to acquire cheaper drugs for its AIDS prevention program. <br /> | May 5, 2007: Brazil President Luiz Inacio Lula da Silva has authorised the country to break the patent on an AIDS drug made by Merck & Co - importing a generic version from India instead. It`s the first time Brazil has bypassed a patent to acquire cheaper drugs for its AIDS prevention program. <br /> | ||
Latest revision as of 01:26, 6 October 2008
Blah
Brazil breaks AIDS drug patent with generic version from India
May 5, 2007: Brazil President Luiz Inacio Lula da Silva has authorised the country to break the patent on an AIDS drug made by Merck & Co - importing a generic version from India instead. It`s the first time Brazil has bypassed a patent to acquire cheaper drugs for its AIDS prevention program.
Access full article
Brazil bypasses patent on U.S. AIDS drug
May 4, 2007: [BRASILIA, Brazil] President Luiz Inacio Lula da Silva took steps Friday to let Brazil buy or produce an inexpensive generic version of an AIDS drug made by Merck & Co. despite the U.S. drug company's patent.
Access full article
Brazilian Government declares Efavirenz to be of public interest
25 April 2007: Brazil has begun a process which may culminate in the compulsory licensing of the patent of the antiretroviral drug Efavirenz. The Minister of Health, José Gomes Temporão, signed Ministerial Ordinance 866, published today in the Federal Official Gazette, declaring Efavirenz to be of public interest for the purposes of granting compulsory licensing for non-commercial public use.
Read full article
Return to IP Resources page</br>
IP Project Page
